Terug
11
Dagbereik
€ 5,14
€ 5,15
52-Weeksbereik
€ 2,22
€ 5,19
Volume
8.534.627
50D / 200D Gem.
€ 4,38
/
€ 3,28
Vorige Slotkoers
€ 5,14
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 110,2 | 0,4 |
| P/B | 7,3 | 2,9 |
| ROE % | 6,7 | 3,8 |
| Net Margin % | 3,4 | 3,9 |
| Rev Growth 5Y % | 19,1 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 5,42
+5.4%
Low: € 5,00
High: € 6,00
Forward K/W
37,9
Forward WPA
€ 0,14
WPA Groei (sch.)
+0,0%
Omzet Sch.
280 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,58
€ 0,57 – € 0,59
|
600 M | 1 |
| FY2029 |
€ 0,41
€ 0,40 – € 0,42
|
490 M | 1 |
| FY2028 |
€ 0,32
€ 0,31 – € 0,32
|
410 M | 2 |
Belangrijkste Punten
Revenue grew 19,12% annually over 5 years — strong growth
Earnings grew 578,83% over the past year
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -2,11M
P/E of 110,20 — premium valuation
PEG of 0,13 suggests growth is underpriced
Groei
Revenue Growth (5Y)
19,12%
Revenue (1Y)22,00%
Earnings (1Y)578,83%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
6,65%
ROIC2,02%
Net Margin3,40%
Op. Margin1,38%
Veiligheid
Debt / Equity
0,00
Current Ratio6,38
Interest Coverage0,00
Waardering
P/E Ratio
110,20
P/B Ratio7,34
EV/EBITDA260,60
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22,00% | Revenue Growth (3Y) | 23,51% |
| Earnings Growth (1Y) | 578,83% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 19,12% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 228,87M | Net Income (TTM) | 7,79M |
| ROE | 6,65% | ROA | 5,78% |
| Gross Margin | 42,97% | Operating Margin | 1,38% |
| Net Margin | 3,40% | Free Cash Flow (TTM) | -2,11M |
| ROIC | 2,02% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 6,38 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 110,20 | P/B Ratio | 7,34 |
| P/S Ratio | 3,75 | PEG Ratio | 0,13 |
| EV/EBITDA | 260,60 | Dividend Yield | 0,00% |
| Market Cap | 858,77M | Enterprise Value | 821,42M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 228,87M | 187,59M | 150,05M | 119,57M | 113,67M |
| Net Income | 7,79M | 1,15M | -19,18M | -79,67M | -62,74M |
| EPS (Diluted) | 0,04 | 0,01 | -0,12 | -0,51 | -0,72 |
| Gross Profit | 98,35M | 85,84M | 74,38M | 60,34M | 66,77M |
| Operating Income | 3,15M | -4,50M | -23,21M | -77,02M | -93,92M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 134,86M | 138,68M | 142,22M | 156,25M | 223,61M |
| Total Liabilities | 17,85M | 21,28M | 23,58M | 28,72M | 31,33M |
| Shareholders' Equity | 117,02M | 117,40M | 118,65M | 127,54M | 192,27M |
| Total Debt | 0,0 | 0,0 | 0,0 | 500.000,0 | 0,0 |
| Cash & Equivalents | 37,35M | 76,69M | 123,91M | 138,55M | 198,26M |
| Current Assets | 111,06M | 130,18M | 139,80M | 152,56M | 213,33M |
| Current Liabilities | 17,40M | 19,02M | 21,65M | 27,32M | 27,18M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#142 of 146
Recente Activiteit
Ingestapt
Full Throttle
Mar 24, 2026